HIF1A and breast cancer: The algal metabolite enhanced the degradation of HIF-1α in breast cancer T47D cells, with an IC50 value as low as 0.4 μM, exhibiting selective anticancer effects under hypoxic conditions without affecting normoxic cell growth [276].